INDV Stock Up 29% after 7-Day Win Streak

INDV: Indivior Pharmaceuticals logo
INDV
Indivior Pharmaceuticals

Indivior (INDV) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 29% return. The company has gained about $775 Mil in value over the last 7 days, with its current market capitalization at about $2.7 Bil. The stock remains 77.0% above its value at the end of 2024. This compares with year-to-date returns of 7.9% for the S&P 500.

INDV develops, manufactures, and sells buprenorphine-based prescription drugs for treating opioid dependence and related disorders. After this rally, is INDV still a buy – or is it time to lock in gains? Deep dive with Buy or Sell INDV.

Comparing INDV Stock Returns With The S&P 500

The following table summarizes the return for INDV stock vs. the S&P 500 index over different periods, including the current streak:
 

Relevant Articles
  1. Why Did Robinhood Stock Fall?
  2. Safe Haven Or Just Another Trade? The New Reality For Gold And Silver
  3. Should You Buy CrowdStrike Stock After Its Recent Pullback?
  4. BMNR Stock At $23: Buy Ethereum At A Discount?
  5. Earn 9.4% Today or Buy CROX 40% Cheaper – It’s a Win-Win
  6. Triggers That Could Ignite the Next Rally In Applied Materials Stock

Return Period INDV S&P 500
1D 0.9% 0.7%
7D (Current Streak) 28.7% -0.7%
1M (21D) 45.0% 1.9%
3M (63D) 88.0% 13.2%
YTD 2025 77.0% 7.9%
2024 -18.6% 23.3%
2023 -29.8% 24.2%
2022 530.4% -19.4%

 
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has INDV behaved after prior drops? See INDV Dip Buyer Analysis to learn more.

Gains and Losses Streaks: S&P 500 Constituents

There are currently 86 S&P constituents with 3 days or more of consecutive gains and 15 constituents with 3 days or more of consecutive losses.
 

Consecutive Days # of Gainers # of Losers
3D 65 7
4D 17 2
5D 4 1
6D 0 4
7D or more 0 1
Total >=3 D 86 15

 
 
Key Financials for Indivior (INDV)

Last 2 Fiscal Years:

Metric FY2023 FY2024
Revenues $1.1 Bil $1.2 Bil
Operating Income $243.0 Mil $228.0 Mil
Net Income $-129.0 Mil $2.0 Mil

Last 2 Fiscal Quarters:

Metric 2024 FQ4 2025 FQ1
Revenues $299.0 Mil $266.0 Mil
Operating Income $292.0 Mil $68.0 Mil
Net Income $59.0 Mil $47.0 Mil

 
While INDV stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.